Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Webster

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
International Journal of Cardiology|March 11, 2020
Diagnostic coronary angiography and percutaneous coronary intervention practices in New Zealand: The All New Zealand Acute Coronary Syndrome-Quality Improvement CathPCI registry 3-year study (ANZACS-QI 37)Tom Kai Ming Wang, Chethan Kasargod, Daniel Chan, et al.
Heart, Lung & Circulation|August 10, 2014
A review of a regional primary percutaneous coronary intervention service, with a focus on door to reperfusion times: the 2012 Auckland/Northland experienceAaron Lin, Timothy Oh, Mohammed Alawami, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 12, 2005
IMPACT Trial: angiographic and intravascular ultrasound observations of the first human experience with mycophenolic acid-eluting polymer stent systemAlexandre Abizaid, Mariano Albertal, John Ormiston, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 8, 2009
The Mesothelioma and Radical surgery randomized controlled trial: the Mars feasibility studyTom Treasure, David Waller, Carol Tan, et al.
JACC. Cardiovascular Interventions|March 9, 2025
Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent: 2-Year Outcomes From BIOADAPTOR RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Eclinicalmedicine|December 18, 2023
First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with <i>de novo</i> coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 28, 2025
Site-Specific Antithrombotic Therapy: 24-Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple-Drug Eluting Coronary Implant With Two Anticoagulants and SirolimusStefan Verheye, Bert Ferdinande, Johan Bennett, et al.
Theranostics|September 11, 2013
Bioengineering silicon quantum dot theranostics using a network analysis of metabolomic and proteomic data in cardiac ischemiaFolarin Erogbogbo, Jasmine May, Mark Swihart, et al.
American Heart Journal|November 8, 2020
Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: The LANDMARK trialHideyuki Kawashima, Osama Soliman, Rutao Wang, et al.
Lancet (London, England)|May 25, 2024
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trialAndreas Baumbach, Niels van Royen, Ignacio J Amat-Santos, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
International Journal of Cardiology|March 11, 2020
Diagnostic coronary angiography and percutaneous coronary intervention practices in New Zealand: The All New Zealand Acute Coronary Syndrome-Quality Improvement CathPCI registry 3-year study (ANZACS-QI 37)Tom Kai Ming Wang, Chethan Kasargod, Daniel Chan, et al.
Heart, Lung & Circulation|August 10, 2014
A review of a regional primary percutaneous coronary intervention service, with a focus on door to reperfusion times: the 2012 Auckland/Northland experienceAaron Lin, Timothy Oh, Mohammed Alawami, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 12, 2005
IMPACT Trial: angiographic and intravascular ultrasound observations of the first human experience with mycophenolic acid-eluting polymer stent systemAlexandre Abizaid, Mariano Albertal, John Ormiston, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 8, 2009
The Mesothelioma and Radical surgery randomized controlled trial: the Mars feasibility studyTom Treasure, David Waller, Carol Tan, et al.
JACC. Cardiovascular Interventions|March 9, 2025
Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent: 2-Year Outcomes From BIOADAPTOR RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Eclinicalmedicine|December 18, 2023
First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with <i>de novo</i> coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 28, 2025
Site-Specific Antithrombotic Therapy: 24-Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple-Drug Eluting Coronary Implant With Two Anticoagulants and SirolimusStefan Verheye, Bert Ferdinande, Johan Bennett, et al.
Theranostics|September 11, 2013
Bioengineering silicon quantum dot theranostics using a network analysis of metabolomic and proteomic data in cardiac ischemiaFolarin Erogbogbo, Jasmine May, Mark Swihart, et al.
American Heart Journal|November 8, 2020
Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: The LANDMARK trialHideyuki Kawashima, Osama Soliman, Rutao Wang, et al.
Lancet (London, England)|May 25, 2024
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trialAndreas Baumbach, Niels van Royen, Ignacio J Amat-Santos, et al.
Pageof 11